129 related articles for article (PubMed ID: 36054582)
1. Clinical features and outcomes of renal amyloidosis in Hong Kong.
Lin RCC; Yuen SK; Cheung SF; Tang HL; Fung SKS
Nephrology (Carlton); 2022 Nov; 27(11):869-876. PubMed ID: 36054582
[TBL] [Abstract][Full Text] [Related]
2. Light-chain amyloidosis with renal involvement: renal outcomes and validation of two renal staging systems in the Chinese population.
Zhu Z; Yue C; Sun Y; Li X; Li M
Amyloid; 2019 Dec; 26(4):186-191. PubMed ID: 31339366
[No Abstract] [Full Text] [Related]
3. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
[TBL] [Abstract][Full Text] [Related]
4. Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis.
Nader R; Zhen A; Angel-Korman A; Pavlovich SS; Pogrebinsky A; Doros G; Menn-Josephy H; Stern L; Sanchorawala V; Havasi A
Nephrol Dial Transplant; 2022 Jun; 37(7):1281-1288. PubMed ID: 34043009
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation.
Fenoglio R; Baldovino S; Ferro M; Sciascia S; Rabajoli G; Quattrocchio G; Beltrame G; Naretto C; Rossi D; Alpa M; Barreca A; Papotti MG; Roccatello D
J Nephrol; 2021 Feb; 34(1):231-240. PubMed ID: 32472525
[TBL] [Abstract][Full Text] [Related]
6. Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy.
Kastritis E; Gavriatopoulou M; Roussou M; Migkou M; Fotiou D; Ziogas DC; Kanellias N; Eleutherakis-Papaiakovou E; Panagiotidis I; Giannouli S; Psimenou E; Marinaki S; Apostolou T; Gakiopoulou H; Tasidou A; Papassotiriou I; Terpos E; Dimopoulos MA
Am J Hematol; 2017 Jul; 92(7):632-639. PubMed ID: 28370245
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis.
Rezk T; Gilbertson JA; Rowczenio D; Bass P; Lachmann HJ; Wechalekar AD; Fontana M; Mahmood S; Sachchithanantham S; Whelan CJ; Wong J; Rendell N; Taylor GW; Hawkins PN; Gillmore JD
Nephrol Dial Transplant; 2018 Feb; 33(2):241-247. PubMed ID: 29401357
[TBL] [Abstract][Full Text] [Related]
8. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory profile of renal amyloidosis: A single-center experience.
Engineer DP; Kute VB; Patel HV; Shah PR
Saudi J Kidney Dis Transpl; 2018; 29(5):1065-1072. PubMed ID: 30381502
[TBL] [Abstract][Full Text] [Related]
10. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
[TBL] [Abstract][Full Text] [Related]
11. Rapid decline of renal function in patients with type 2 diabetes with heavy proteinuria: a report of three cases.
Lim CTS; Nordin NZ; Fadhlina NZ; Anim MS; Kalaiselvam T; Haikal WZ; Goh BL
BMC Nephrol; 2019 Jan; 20(1):22. PubMed ID: 30651084
[TBL] [Abstract][Full Text] [Related]
12. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
13. Renal outcomes of autologous stem cell transplantation among patients with light-chain amyloidosis: a single centre Spanish experience.
Azorín SE; Cibeira MT; Solé M; Fernández de Larrea C; Rosiñol L; Rovira M; Campistol JM; Bladé J
Amyloid; 2017 Mar; 24(sup1):70-71. PubMed ID: 28434321
[No Abstract] [Full Text] [Related]
14. How I Approach Light Chain Amyloidosis.
Chowdhury RB; Leung N
G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007836
[TBL] [Abstract][Full Text] [Related]
15. A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.
Palladini G; Hegenbart U; Milani P; Kimmich C; Foli A; Ho AD; Vidus Rosin M; Albertini R; Moratti R; Merlini G; Schönland S
Blood; 2014 Oct; 124(15):2325-32. PubMed ID: 25115890
[TBL] [Abstract][Full Text] [Related]
16. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis.
Said SM; Sethi S; Valeri AM; Chang A; Nast CC; Krahl L; Molloy P; Barry M; Fidler ME; Cornell LD; Leung N; Vrana JA; Theis JD; Dogan A; Nasr SH
Kidney Int; 2014 Aug; 86(2):370-7. PubMed ID: 24451324
[TBL] [Abstract][Full Text] [Related]
17. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.
Liang S; Le W; Liang D; Chen H; Xu F; Chen H; Liu Z; Zeng C
BMC Nephrol; 2016 Apr; 17():42. PubMed ID: 27066888
[TBL] [Abstract][Full Text] [Related]
18. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
19. Renal Amyloidosis: Presentation, Diagnosis, and Management.
Gurung R; Li T
Am J Med; 2022 Apr; 135 Suppl 1():S38-S43. PubMed ID: 35085515
[TBL] [Abstract][Full Text] [Related]
20. Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement.
Oliveira-Silva C; Marques N; Pinho A; Poínhos R; Bergantim R; Nunes AT; Sampaio S; Rodrigues-Pereira P; Silva R; Praça A; Frazão J; Pestana M; Tavares I
Nephron; 2023; 147(3-4):158-169. PubMed ID: 36096123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
